Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG

Elizabeth V Wasmuth1, Elizabeth A Hoover1, Albert Antar2

  • 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.

Insights

Androgen receptor (AR) reprogramming in prostate cancer involves ERG cofactor interaction. This biochemical insight explains how ETS fusions alter AR DNA binding, impacting cancer progression.

Area of Science:

  • Molecular biology
  • Cancer research
  • Biochemistry

Background:

  • The androgen receptor (AR) is a key target in prostate cancer.
  • AR's role in prostate luminal epithelium survival is crucial.
  • AR cistrome reprogramming occurs in prostate cancer, especially with ETS fusions, but the mechanism is unclear.

Purpose of the Study:

  • To elucidate the molecular basis of AR cistrome reprogramming in prostate cancer.
  • To investigate the role of ERG as a cofactor in AR DNA binding.
  • To understand the biochemical interactions driving AR dysregulation in ETS-driven prostate cancers.

Main Methods:

  • Utilized a minimal cell-free system with purified proteins.
  • Investigated interdomain cooperativity within the AR.
  • Identified and characterized the AR-interacting motif (AIM) in the ERG ETS domain.

Main Results:

  • Demonstrated AR interdomain cooperativity and N-terminal autoinhibition.
  • Identified ERG as an AR cofactor that enhances DNA binding.
  • ERG interacts with AR via a novel AIM in the ETS domain, independent of ERG's DNA binding.
  • This interaction is conserved across ETS factors implicated in prostate cancer.

Conclusions:

  • Biochemical insights into AR-mediated transcriptional regulation in prostate cancer.
  • ERG acts as a critical cofactor, reprogramming the AR cistrome.
  • Understanding this interaction mechanism is vital for targeted prostate cancer therapies.

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.8K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.3K